Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answer

Clin Mol Hepatol. 2024 Apr;30(2):144-146. doi: 10.3350/cmh.2024.0115. Epub 2024 Feb 19.

Pin-Nan Cheng¹, Ming-Lung Yu^{2

3}

¹ Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
² Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital; College of Medicine and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
³ School of Medicine and Doctoral Program of Clinical and Experimental Medicine, College of Medicine and Center of Excellence for Metabolic Associated Fatty Liver, National Sun Yat-sen University, Kaohsiung, Taiwan.

No abstract available

Keywords: Good health and well-being; HBV; SDG 3; TAF; TDF.

Publication types